Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours Β· Estimated delivery Sep 1 - Sep 6
It has been demonstrated to reduce body weight by a mean of 15% among patients with overweight or obesity without diabetes
This is a collaborative journey from start to finish
Lose weight, not nutrients The new line is accompanied by a message notifying consumers that they are to lose weight, not nutrients. While GLP-1 drugs are recognized as an effective and rapid slim-down strategy, questions remain around the ramifications and sustainability of the injections for weight loss
Glow comes after
Slows gastric emptying : GLP1 slows the rate at which food moves from the stomach into the small intestine, prolonging fullness and reducing blood sugar spikes
Orforglipron is the first small-molecule GLP-1 receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3 trial
